BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 45 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 71,757,000 | $44,221,686 | 4.15% |
| Context Capital Management, LLC | 33,683 | $20,846 | 1.88% |
| INHERENT GROUP, LP | 9,000,000 | $5,587,173 | 1.54% |
| BRAIDWELL LP | 62,294,000 | $38,552,328 | 1.26% |
| Aequim Alternative Investments LP | 30,000,000 | $18,566,312 | 0.70% |
| DeepCurrents Investment Group LLC | 22,355,000 | $13,838,372 | 0.55% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,500,000 | $3,408,592 | 0.48% |
| ARISTEIA CAPITAL, L.L.C. | 30,280,000 | $18,739,598 | 0.42% |
| Weiss Asset Management LP | 4,500,000 | $2,773,209 | 0.21% |
| Orbimed Advisors | 15,000,000 | $9,265,350 | 0.17% |